galectin

DB21, Galectin-1 Antagonist, is a peptidomimetic conjugated with dibenzofuran, serving as an allosteric inhibitor of galectin-1 (GAL1) interactions with glycans on cell surfaces. This compound enhances the inhibition of angiogenesis and tumor growth in melanoma, lung adenocarcinoma, and ovarian cancer models [1].

G3-C12 acetate shows anticancer activity. is a galectin-3 binding peptide, with Kd of 88 nM.

G3-C12 shows anticancer activity. is a galectin-3 binding peptide, with Kd of 88 nM.

G3-C12 (TFA), a galectin-3 binding peptide, demonstrates anticancer activity with a dissociation constant (K d) of 88 nM.

G3-C12 TFA Salt is a specific galectin-3 binding peptide with Ksubdsub of 88 nM and shows anticancer activity.